Mechanistic studies demonstrated that tumor inhibition was through the suppression of Cyclins A and E via a direct binding between ZHX2 and the promoter domain of Cyclins A and E. The inverse correlation between ZHX2 and Cyclins A and E was further detected from liver cancer tissues. Here, ZHX2 is linked to liver cancer.